Phenotypic expression of maternally inherited deafness is affected by RNA modification and cytoplasmic ribosomal proteins

Molecular Genetics and Metabolism

Volumn 97, Issue 4, 2009, Pages 297-304

  Bykhovskaya, Yelena ^a   Mengesha, Emebet ^a   Fischel Ghodsian, Nathan ^a  

^a Steven Spielberg Pediatric Research Center   (United States)

Author keywords

Complex disease; Deafness; Mitochondrial; Phenotype; Ribosome; RNA modification; Systems biology

Indexed keywords

MAX PROTEIN; MYC PROTEIN; RIBOSOME PROTEIN; RNA; RNA BINDING PROTEIN;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOPLASM; DISEASE SEVERITY; DNA MODIFICATION; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; GENE MUTATION; HEARING IMPAIRMENT; HEARING LOSS; HUMAN; LYMPHOBLAST; MALE; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA TRANSCRIPTION; UPREGULATION;

DEAFNESS; FEMALE; GENE EXPRESSION PROFILING; HEARING LOSS; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHENOTYPE; RIBOSOMAL PROTEINS; RNA; RNA, RIBOSOMAL; RNA-BINDING PROTEINS;

HUMAN HERPESVIRUS 4;

EID: 67650001621     PISSN: 10967192     EISSN: 10967206     Source Type: Journal    
DOI: 10.1016/j.ymgme.2009.05.003     Document Type: Article

References (46)

1. Scheper G.C., van der Klok T., van Andel R.J., van Berkel C.G., Sissler M., Smet J., Muravina T.I., Serkov S.V., Uziel G., Bugiani M., Schiffmann R., Krageloh-Mann I., Smeitink J.A., Florentz C., van Coster R., Pronk J.C., and van der Knaap M.S. Mitochondrial aspartyl-tRNA synthetase deficiency causes leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation. Nat. Genet. 39 (2007) 534-539
2. Jacobs H.T., and Turnbull D.M. Nuclear genes and mitochondrial translation: a new class of genetic disease. Trends Genet. 21 (2005) 312-314
3. Taylor R.W., and Turnbull D.M. Mitochondrial DNA mutations in human disease. Nat. Rev. Genet. 6 (2005) 389-402
4. Miller C., Saada A., Shaul N., Shabtai N., Ben-Shalom E., Shaag A., Hershkovitz E., and Elpeleg O. Defective mitochondrial translation due to a ribosomal protein (MRPS16) mutation. Ann. Neurol. 56 (2004) 734-738
5. Saada A., Shaag A., Arnon S., Dolfin T., Miller C., Fuchs-Telem D., Lombes A., and Elpeleg O. Antenatal mitochondrial disease caused by mitochondrial ribosomal protein (MRPS22) mutation. J. Med. Genet. 44 (2007) 784-786
6. Edvardson S., Shaag A., Kolesnikova O., Gomori J.M., Tarassov I., Einbinder T., Saada A., and Elpeleg O. Deleterious mutation in the mitochondrial arginyl-transfer RNA synthetase gene is associated with pontocerebellar hypoplasia. Am. J. Hum. Genet. 81 (2007) 857-862
7. Smeitink J.A., Elpeleg O., Antonicka H., Diepstra H., Saada A., Smits P., Sasarman F., Vriend G., Jacob-Hirsch J., Shaag A., Rechavi G., Welling B., Horst J., Rodenburg R.J., van den Heuvel B., and Shoubridge E.A. Distinct clinical phenotype associated with a mutation in the mitochondrial translation elongation factor EFTs. Am. J. Hum. Genet. 79 (2006) 869-877
8. Valente L., Tiranti V., Marsano R.M., Malfatti E., Fernandez-Vizarra E., Donnini C., Mereghetti P., De Gioia L., Burlina A., Castellan C., Comi G.P., Savasta S., Ferrero I., and Zeviani M. Infantile encephalopathy and defective mitochondrial DNA translation in patients with mutations of mitochondrial elongation factors EFG1 and EFTu. Am. J. Hum. Genet. 80 (2007) 44-58
9. 't Hart L.M., Hansen T., Rietveld I., Dekker J.M., Nijpels G., Janssen G.M., Arp P.A., Uitterlinden A.G., Jorgensen T., Borch-Johnsen K., Pols H.A., Pedersen O., van Duijn C.M., Heine R.J., and Maassen J.A. Evidence that the mitochondrial leucyl tRNA synthetase (LARS2) gene represents a novel type 2 diabetes susceptibility gene. Diabetes 54 (2005) 1892-1895
10. Coenen M.J., Antonicka H., Ugalde C., Sasarman F., Rossi R., Heister J.G., Newbold R.F., Trijbels F.J., van den Heuvel L.P., Shoubridge E.A., and Smeitink J.A. Mutant mitochondrial elongation factor G1 and combined oxidative phosphorylation deficiency. N. Engl. J. Med. 351 (2004) 2080-2086
11. Antonicka H., Sasarman F., Kennaway N.G., and Shoubridge E.A. The molecular basis for tissue specificity of the oxidative phosphorylation deficiencies in patients with mutations in the mitochondrial translation factor EFG1. Hum. Mol. Genet. 5 (2006) 1835-1846
12. Jeppesen T.D., Schwartz M., Frederiksen A.L., Wibrand F., Olsen D.B., and Vissing J. Muscle phenotype and mutation load in 51 persons with the 3243A>G mitochondrial DNA mutation. Arch. Neurol. 63 (2006) 1701-1706
13. Fischel-Ghodsian N. Mitochondrial genetics and hearing loss: the missing link between genotype and phenotype. Proc. Soc. Exp. Biol. Med. 218 (1998) 1-6
14. Fischel-Ghodsian N. Homoplasmic mitochondrial diseases as the paradigm to understand the tissue specificity and variable clinical severity of mitochondrial disorders. Mol. Genet. Metab. 71 (2000) 93-99
15. Prezant T.R., Agapian J.V., Bohlman M.C., Bu X., Öztas S., Qiu W.Q., Arnos K.S., Cortopassi G.A., Jaber L., Rotter J.I., Shohat M., and Fischel-Ghodsian N. Mitochondrial ribosomal RNA mutation associated with both antibiotic-induced and non-syndromic deafness. Nat. Genet. 4 (1993) 289-294
16. Bykhovskaya Y., Mengesha E., Wang D., Yang H., Estivill X., Shohat M., and Fischel-Ghodsian N. Human mitochondrial transcription factor B1 as a modifier gene for hearing loss associated with the mitochondrial A1555G mutation. Mol. Genet. Metab. 82 (2004) 27-32
17. Bykhovskaya Y., Mengesha E., Wang D., Yang H., Estivill X., Shohat M., and Fischel-Ghodsian N. Phenotype of non-syndromic deafness associated with the mitochondrial A1555G mutation is modulated by mitochondrial RNA modifying enzymes MTO1 and GTPBP3. Mol. Genet. Metab. 83 (2004) 199-206
18. Yan Q., Bykhovskaya Y., Li R., Mengesha E., Shohat M., Estivill X., Fischel-Ghodsian N., and Guan M.X. Human TRMU encoding the mitochondrial 5-methylaminomethyl-2-thiouridylate methyltransferase is a putative nuclear modifier gene for the phenotypic expression of the deafness-associated 12S rRNA mutations. Biochem. Biophys. Res. Commun. 342 (2006) 1130-1136
19. Guan M.X., Yan Q., Li X., Bykhovskaya Y., Gallo-Teran J., Hajek P., Umeda N., Zhao H., Garrido G., Mengesha E., Suzuki T., del Castillo I., Peters J.L., Li R., Qian Y., Wang X., Ballana E., Shohat M., Lu J., Estivill X., Watanabe K., and Fischel-Ghodsian N. Mutation in TRMU related to transfer RNA modification modulates the phenotypic expression of the deafness-associated mitochondrial 12S ribosomal RNA mutations. Am. J. Hum. Genet. 79 (2006) 291-302
20. Jaber L., Shohat M., Bu X., Fischel-Ghodsian N., Yang H.Y., Wang S.J., and Rotter J.I. Sensorineural deafness inherited as a tissue specific mitochondrial disorder. J. Med. Genet. 29 (1992) 86-90
21. Hosack D.A., Dennis Jr. G., Sherman B.T., Lane H.C., and Lempicki R.A. Identifying biological themes within lists of genes with EASE. Genome Biol. 4 (2003) R70
22. Morello F., de Bruin T.W., Rotter J.I., Pratt R.E., van der Kallen C.J., Hladik G.A., Dzau V.J., Liew C.C., and Chen Y.D. Differential gene expression of blood-derived cell lines in familial combined hyperlipidemia. Arterioscler. Thromb. Vasc. Biol. 24 (2004) 2149-2154
23. Haas C.S., Creighton C.J., Pi X., Maine I., Koch A.E., Haines G.K., Ling S., Chinnaiyan A.M., and Holoshitz J. Identification of genes modulated in rheumatoid arthritis using complementary DNA microarray analysis of lymphoblastoid B cell lines from disease-discordant monozygotic twins. Arthritis Rheum. 54 (2006) 2047-2060
24. Watts J.A., Morley M., Burdick J.T., Fiori J.L., Ewens W.J., Spielman R.S., and Cheung V.G. Gene expression phenotype in heterozygous carriers of ataxia telangiectasia. Am. J. Hum. Genet. 71 (2002) 791-800
25. Dennis Jr. G., Sherman B.T., Hosack D.A., Yang J., Gao W., Lane H.C., and Lempicki R.A. DAVID: database for annotation, visualization, and integrated discovery. Genome Biol. 4 (2003) P3
26. Ashburner M., Ball C.A., Blake J.A., Botstein D., Butler H., Cherry J.M., Davis A.P., Dolinski K., Dwight S.S., Eppig J.T., Harris M.A., Hill D.P., Issel-Tarver L., Kasarskis A., Lewis S., Matese J.C., Richardson J.E., Ringwald M., Rubin G.M., and Sherlock G. The gene ontology consortium, gene ontology: tool for the unification of biology. Nature Genet. 25 (2000) 25-29
27. Boon K., Caron H.N., van Asperen R., Valentijn L., Hermus M.C., van Sluis P., Roobeek I., Weis I., Voute P.A., Schwab M., and Versteeg R. N-myc enhances the expression of a large set of genes functioning in ribosome biogenesis and protein synthesis. EMBO J. 20 (2001) 1383-1393
28. Blackwood E.M., and Eisenman R.N. Max: a helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc. Science 251 (1991) 1211-1217
29. Crimi M., O'Hearn S.F., Wallace D.C., and Comi G.P. Molecular research technologies in mitochondrial diseases: the microarray approach. IUBMB Life 57 (2005) 811-818
30. Crimi M., Bordón A., Menozzi G., Riva L., Fortunato F., Galbiati S., Del Bo R., Pozzoli U., Bresolin N., and Comi G.P. Skeletal muscle gene expression profiling in mitochondrial disorders. FASEB J. 19 (2005) 866-868
31. Mootha V.K., Lepage P., Miller K., Bunkenborg J., Reich M., Hjerrild M., Delmonte T., Villeneuve A., Sladek R., Xu F., Mitchell G.A., Morin C., Mann M., Hudson T.J., Robinson B., Rioux J.D., and Lander E.S. Identification of a gene causing human cytochrome c oxidase deficiency by integrative genomics. Proc. Natl. Acad. Sci. USA 100 (2003) 605-610
32. Bykhovskaya Y., Casas K., Mengesha E., Inbal A., and Fischel-Ghodsian N. Missense mutation in pseudouridine synthase 1 (PUS1) causes mitochondrial myopathy and sideroblastic anemia (MLASA). Am. J. Hum. Genet. 74 (2004) 1303-1308
33. Lederer C.W., Torrisi A., Pantelidou M., Santama N., and Cavallaro S. Pathways and genes differentially expressed in the motor cortex of patients with sporadic amyotrophic lateral sclerosis. BMC Genomics 8 (2007) 26
34. Bykhovskaya Y., Mengesha E., and Fischel-Ghodsian N. Pleiotropic effects and compensation mechanisms determine tissue specificity in mitochondrial myopathy and sideroblastic anemia (MLASA). Mol. Genet. Metab. 91 (2007) 148-156
35. Barna M., Pusic A., Zollo O., Costa M., Kondrashov N., Rego E., Rao P.H., and Ruggero D. Suppression of Myc oncogenic activity by ribosomal protein haploinsufficiency. Nature 456 (2008) 971-975
36. Ryan K.M., and Birnie G.D. Myc oncogenes: the enigmatic family. Biochem. J. 314 (1996) 713-721
37. Guan M.X., Fischel-Ghodsian N., and Attardi G. Biochemical evidence for nuclear gene involvement in phenotype of non-syndromic deafness associated with mitochondrial 12S rRNA mutation. Hum. Mol. Genet. 5 (1996) 963-971
38. Hobbie S.N., Bruell C.M., Akshay S., Kalapala S.K., Shcherbakov D., and Bottger E.C. Mitochondrial deafness alleles confer misreading of the genetic code. Proc. Natl. Acad. Sci. USA 105 (2008) 3244-3249
39. Sevior K.B., Hatamochi A., Stewart I.A., Bykhovskaya Y., Allen-Powell D.R., Fischel-Ghodsian N., and Maw M.A. Mitochondrial A7445G mutation in two pedigrees with palmoplantar keratoderma and deafness. Am. J. Med. Genet. 75 (1998) 179-185
40. Wang X., Lu J., Zhu Y., Yang A., Yang L., Li R., Chen B., Qian Y., Tang X., Wang J., Zhang X., and Guan M.X. Mitochondrial tRNAThr G15927A mutation may modulate the phenotypic manifestation of ototoxic 12S rRNA A1555G mutation in four Chinese families. Pharmacogenet. Genomics 18 (2008) 1059-1070
41. Young W.Y., Zhao L., Qian Y., Li R., Chen J., Yuan H., Dai P., Zhai S., Han D., and Guan M.X. Variants in mitochondrial tRNAGlu, tRNAArg, and tRNAThr may influence the phenotypic manifestation of deafness-associated 12S rRNA A1555G mutation in three Han Chinese families with hearing loss. Am. J. Med. Genet. A. 140 (2006) 2188-2197
42. Chen B., Sun D., Yang L., Zhang C., Yang A., Zhu Y., Zhao J., Chen Y., Guan M., Wang X., Li R., Tang X., Wang J., Tao Z., Lu J., and Guan M.X. Mitochondrial ND5 T12338C, tRNACys T5802C, and tRNAThr G15927A variants may have a modifying role in the phenotypic manifestation of deafness-associated 12S rRNA A1555G mutation in three Han Chinese pedigrees. Am. J. Hum. Genet. A. 146 (2008) 1248-1258
43. Fischel-Ghodsian N. Genetic factors in aminoglycoside toxicity. Pharmacogenomics 6 (2005) 27-36
44. Talaska A.E., Schacht J., and Fischel-Ghodsian N. Molecular and genetic aspects of aminoglycoside-induced hearing loss. Drug Discov. Today Disease Mech. 3 (2006) 119-124
45. Hamasaki K., and Rando R.R. Specific binding of aminoglycosides to a human rRNA construct based on a DNA polymorphism which causes aminoglycoside-induced deafness. Biochem. J. 36 (1997) 12323-12328
46. Guan M.X., Fischel-Ghodsian N., and Attardi G.A. Biochemical basis for the inherited susceptibility to aminoglycoside ototoxicity. Hum. Mol. Genet. 9 (2000) 1787-1793